Every Form 4 that Natural Alternatives International Inc. (NAII) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NAII and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NAII filings page.
NATURAL ALTERNATIVES INTERNATIONAL INC President, COO & Secretary Kenneth Wolf reported routine equity compensation activity. On March 6, 2026, 5,151 shares of common stock were transferred back to the company at $2.73 per share to cover his tax liability tied to the vesting of 9,166 restricted shares on March 7, 2026. He also received a grant of 15,000 shares of restricted stock under the company’s 2020 Omnibus Incentive Plan, which vest in three equal installments of 5,000 shares on March 7, 2027, March 7, 2028, and March 7, 2029. After these transactions, he directly holds 141,831 common shares.
NATURAL ALTERNATIVES INTERNATIONAL INC Chief Financial Officer Michael E. Fortin reported compensation-related stock activity. He received a grant of 12,000 shares of common stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. In a related move, 4,308 shares were transferred back to the company at $2.73 per share to cover his tax liability upon vesting of 7,666 restricted shares on March 7, 2026. One-third of the new 12,000-share grant, or 4,000 shares, vests on each of March 7, 2027, March 7, 2028, and March 7, 2029. After these transactions, Fortin directly holds 58,554 common shares and indirectly holds 185 shares through an IRA.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux received a grant of 20,000 shares of common stock as restricted stock under the 2020 Omnibus Incentive Plan. Following this award, his direct holdings increased to 176,737 common shares.
On the same date, 3,484 shares were transferred back to the company at $2.73 per share to pay his tax liability arising from the vesting of 10,667 restricted shares on March 7, 2026, a tax-withholding disposition rather than an open-market sale. The new 20,000-share grant vests in three equal annual installments of 6,667, 6,667 and 6,666 shares on March 7, 2027, 2028 and 2029. He also reports additional indirect holdings through a family limited partnership, an IRA and custodial accounts.
Dunn Alan G reported acquisition or exercise transactions in this Form 4 filing.
Natural Alternatives International director Alan G. Dunn received a grant of 8,000 shares of Common Stock as restricted stock under the company’s 2020 Omnibus Incentive Plan. One-third vests on March 7, 2027, another third on March 7, 2028, and the final third on March 7, 2029. Following this award, he directly holds 99,211 shares.
Matherly Laura Kay reported acquisition or exercise transactions in this Form 4 filing.
NATURAL ALTERNATIVES INTERNATIONAL INC granted director Laura Kay Matherly 8,000 shares of restricted common stock as compensation under its 2020 Omnibus Incentive Plan. One-third of the award, or 2,667 shares, vests on March 7, 2027, another 2,667 shares on March 7, 2028, and the remaining 2,666 shares on March 7, 2029. After this grant, she directly holds 42,000 common shares.
Ramanathan Guru reported acquisition or exercise transactions in this Form 4 filing.
Natural Alternatives International director Guru Ramanathan received a grant of 8,000 shares of restricted common stock as equity compensation under the company’s 2020 Omnibus Incentive Plan. These shares were granted at no cash cost and increase his direct holdings to 38,000 shares.
The restricted stock vests in three equal annual installments: 2,667 shares on March 7, 2027, 2,667 shares on March 7, 2028, and 2,666 shares on March 7, 2029. This structure is designed to vest over three years of continued board service.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of the company’s common stock. Over three days, he bought a total of 1,250 shares at prices ranging from $2.75 to $2.80 per share, increasing his direct ownership.
After these purchases, his directly held stake rose to 160,221 common shares. The filing also lists additional indirect holdings in the company’s stock through a family limited partnership, an IRA, and custodial accounts for family members, reflecting both personal and family-related ownership positions.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of a total of 1,000 shares of common stock, buying 500 shares at $2.85 on February 27, 2026 and 500 shares at $2.79 on March 2, 2026. Following these trades, his directly held stake rose to 158,971 shares. The filing also lists additional indirect holdings in a family limited partnership, an IRA, and several custodial accounts as of February 27, 2026.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO/Chairman and 10% owner Mark A. LeDoux reported buying additional common shares in the open market. On February 25–27, 2026, he made three open-market purchases totaling 1,250 shares at prices between $2.8000 and $2.8460 per share. After these transactions, his directly held stake rose to 157,971 common shares. He also reported indirect ownership positions held through the LeDoux Family Limited Partnership, an IRA, and several custodial accounts for family members, which are disclosed as separate indirect holdings.
Natural Alternatives International CEO and Chairman Mark A. LeDoux reported open-market purchases of company common stock. He bought 2,000 shares across three trades between February 20 and 24, 2026 at prices from $2.655 to $2.71 per share, increasing his direct holdings to 156,971 shares. He also reports indirect ownership positions through a family limited partnership, an IRA, and several custodial accounts, with updated share amounts for each as of February 20, 2026.
NATURAL ALTERNATIVES INTERNATIONAL INC CEO and Chairman Mark A. LeDoux reported open-market purchases of the company’s common stock. On February 19, he bought 1,500 shares at $2.555 per share, bringing his directly held stake to 154,721 shares afterward.
He also bought 500 shares at $2.563 per share on February 18 and 2,500 shares at $2.596 per share on February 17. The filing also lists indirect holdings, including 481,905 shares held by LeDoux Family Limited Partnership and additional shares held through an IRA and custodial accounts.